(MedPage Today) -- The TIOSPIR trial was used to support safety of the mist inhaler version of tiotropium (Spiriva) compared with dry powder, but the pooled data actually showed something else -- a heart attack signal, researchers argued. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment